The company's capital adequacy is under severe pressure, as total liabilities of $1.0 billion now dwarf the minimal equity base of $2.1 million reported in 2026Q1.
| Total Assets | 917.92M | 987.38M | 1.49B | 1.5B | 1.66B | 2.07B | 2.11B | 1.6B | 142.84M |
| Asset Growth % | -86.12% | -33.66% | -0.74% | -9.63% | -19.8% | -1.89% | 31.61% | 1021.76% | - |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 264.9M | 285.79M | 400.41M | 476.44M | 414.56M | 429M | 391.82M | 143.77M | 54.03M |
| Cash & Equivalents | 39.88M | 32.9M | 40.92M | 90.81M | 16.46M | 84.36M | 144.23M | 12.28M | 505K |
| Receivables | 1.56B | 239.72M | 324.85M | 336.46M | 340.5M | 285.94M | 215.24M | 125.54M | 48.54M |
| Other Current Assets | -627.36M | 13.17M | 34.64M | 49.17M | 57.59M | 0 | 3.4M | 0 | 0 |
| Goodwill & Intangibles | 202.47M | 0 | 302.5M | 396.55M | 500.61M | 594.67M | 1.08B | 1.17B | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 386.55M | 386.55M | 0 |
| Intangible Assets | 0 | 0 | 302.5M | 396.55M | 500.61M | 594.67M | 688.73M | 782.78M | 0 |
| PP&E (Net) | 13.94M | 14.77M | 48.64M | 48.84M | 46.77M | 47.73M | 17.35M | 6.34M | 11.78M |
| Other Assets | 639.08M | 686.82M | 736.88M | 577.74M | 697.36M | 997.45M | 624.34M | 282.85M | -65.81M |
| Total Liabilities | 1.04B | 992.7M | 1.03B | 1.04B | 1.07B | 1.18B | 709.64M | 742.15M | 329.49M |
| Total Debt | 746.03M | 672.59M | 527.97M | 543.05M | 557.42M | 696.29M | 400.57M | 291.65M | 5.01M |
| Net Debt | 706.15M | 639.69M | 487.05M | 452.24M | 540.96M | 611.93M | 256.34M | 279.38M | 4.5M |
| Long-Term Debt | 708.67M | 636.74M | 447.87M | 422.7M | 504.81M | 665.12M | 396.4M | 288.23M | 0 |
| Short-Term Debt | 2.38M | 0 | 39.5M | 75M | 5.27M | 5.27M | 4.17M | 3M | 4.86M |
| Total Current Liabilities | 10.56M | 141.5M | 338.05M | 370.01M | 265.45M | 217.07M | 127.37M | 113.06M | 47.98M |
| Accounts Payable | 8.47M | 70.87M | 113.36M | 144.97M | 137.17M | 144M | 8.73M | 69.58M | 28.87M |
| Deferred Revenue | 23.79M | 25.49M | 53.72M | 52.4M | 50.59M | 536K | 0 | 15.22M | 1.36M |
| Other Current Liabilities | -32.26M | 3.33M | 4.42M | 5.59M | 10.11M | 8.34M | 9.06M | 2.69M | 3.18M |
| Deferred Taxes | 83.35M | 1000K | 1000K | 0 | 0 | 0 | 0 | 243K | 226K |
| Other Liabilities | 255.54M | 167.18M | 186.86M | 212.35M | 258.96M | 274.4M | 185.87M | 340.19M | 28K |
| Total Equity | -126.7M | -5.32M | 458.4M | 454.95M | 591.7M | 892.49M | 1.4B | 860.14M | -182.15M |
| Equity Growth % | -328.78% | -101.16% | 0.76% | -23.11% | -33.7% | -36.21% | 62.67% | 572.22% | - |
| Shareholders Equity | 2.13M | 94.76M | 294.8M | 280.32M | 318.06M | 353.1M | 380.42M | 860.14M | -186.65M |
| Minority Interest | -128.83M | -100.08M | 163.6M | 174.64M | 273.64M | 539.39M | 1.02B | 0 | 4.5M |
| Retained Earnings | -717.5M | -680.33M | -423.21M | -420.28M | -357.02M | -208.32M | -18.8M | 0 | -189.1M |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 32K | 0 | 2.44M |
| Accumulated OCI | -51K | -59K | -151K | -127K | -144K | -59K | 17K | -17K | 14K |
| Return on Equity (ROE) | -462.09% | -113.5% | -0.64% | -12.09% | -20.04% | -16.53% | -3.92% | -12.11% | - |
| Return on Assets (ROA) | -27.3% | -20.77% | -0.2% | -4.01% | -7.98% | -9.07% | -2.39% | -4.71% | 19.68% |
| Equity / Assets | -13.8% | -0.54% | 30.8% | 30.34% | 35.66% | 43.14% | 66.35% | 53.68% | -127.52% |
| Debt / Equity | -5.89x | - | 1.15x | 1.19x | 0.94x | 0.78x | 0.29x | 0.34x | - |
| Book Value per Share | -7.82 | -0.41 | 45.93 | 48.96 | 70.07 | 126.31 | 249.29 | 41.14 | -8.71 |
| Tangible BV per Share | -7.82 | -0.41 | 15.62 | 6.29 | 10.79 | 42.15 | 57.71 | -14.79 | -8.71 |
Liquidity and Regulatory Headwinds
As reported in recent financial statements, GoHealth's equity base has experienced a significant decline, dropping from $280.3 million in 2023Q4 to a mere $2.1 million by 2026Q1, signaling a rapid depletion of shareholder value that suggests the company's current business model is struggling to maintain capital adequacy.
The precipitous drop in equity indicates that the company is consuming its net assets to fund ongoing operations rather than generating internal capital. This trend suggests that the firm's historical reliance on aggressive growth has left it with a fragile balance sheet that may lack the necessary buffer to absorb further operational volatility.
Based on the provided balance sheet data, the company's total liabilities of $1.0 billion significantly outweigh its minimal equity of $2.1 million as of 2026Q1, which appears to indicate a highly leveraged position that leaves little room for error in its ongoing restructuring efforts.
The extreme imbalance between liabilities and equity suggests that the company is operating with virtually no capital cushion. Investors should monitor whether this structure necessitates a dilutive capital raise, as the current level of equity appears insufficient to support the firm's long-term obligations or potential regulatory capital requirements.
According to recent SEC filings, the company's liquidity profile is increasingly constrained, with total assets of $917.9 million as of 2026Q1 largely comprised of non-cash contract assets, leaving the firm with limited immediate resources to meet its substantial $1.0 billion liability burden in the near term.
The absence of a robust cash position relative to its liabilities suggests that the company may face significant liquidity risks if its projected commission inflows are delayed or revised downward. This reliance on future, non-cash contract assets for liquidity warrants further investigation into the firm's ability to sustain operations.
As indicated by the company's financial disclosures, the reliance on contract assets as a primary component of total assets creates a non-obvious risk, as these figures represent estimated future commissions that may be subject to significant impairment if policyholder retention rates fail to meet historical expectations.
The valuation of these assets appears highly sensitive to churn rates and carrier commission adjustments, which are outside the company's direct control. This suggests that the balance sheet may be overstating the firm's true economic value, as these assets are not readily convertible to cash to satisfy immediate obligations.
Quick answers to the most common questions about buying GOCO stock.
As of 2025, GoHealth, Inc. (GOCO) had total assets of $987.4M including $285.8M in current assets.
GoHealth, Inc. (GOCO) carries total debt of $672.6M, offset by $32.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
GoHealth, Inc. (GOCO) has total shareholders' equity (book value) of $94.8M ($-0.41 book value per share). Book value represents the net worth of the company belonging to common stock holders.
GoHealth, Inc. (GOCO) reported a current ratio of 2.02x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.